Fenofibrate Exerts Antitumor Effects in Colon Cancer via Regulation of DNMT1 and CDKN2A
Peroxisome proliferator-activated receptor alpha (PPARA) is the molecular target of fibrates commonly used to treat dyslipidemia and diabetes. Recently, the potential role of PPARA in other pathological conditions, such as cancers, has been recognized. Here, using bioinformatics analysis, we found t...
Saved in:
Main Authors: | Rui Kong, Nan Wang, Wei Han, Wen Bao, Jie Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2021/6663782 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metformin exerted tumoricidal effects on colon cancer tumoroids via the regulation of autophagy pathway
by: Roya Shabkhizan, et al.
Published: (2025-02-01) -
Correlations among PPAR𝜸, DNMT1, and DNMT3B Expression Levels and Pancreatic Cancer
by: Valerio Pazienza, et al.
Published: (2012-01-01) -
Fenofibrate Protects Cardiomyocytes from Hypoxia/Reperfusion- and High Glucose-Induced Detrimental Effects
by: Fabiola Cortes-Lopez, et al.
Published: (2021-01-01) -
Acute Hepatic Failure as a Leading Manifestation in Exertional Heat Stroke
by: Qi Jin, et al.
Published: (2012-01-01) -
Novel Cancer Immunotherapies and Antitumor Immunity
by: Lei Zhao, et al.
Published: (2019-01-01)